Navigation Links
Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders
Date:12/9/2012

ne in Patients with Previously Untreated Multiple Myeloma (MM) [Abstract 332]

Early-stage research suggests that when added to standard multiple myeloma therapy, an investigational oral proteasome inhibitor known as MLN9708 increases the efficacy of treatment with few side effects.

The last decade has seen an explosion of new therapies for myeloma, a disease that causes the plasma cells found in the bone marrow to grow uncontrollably and form tumors. These tumor cells can destroy bones, damage kidneys, and make it difficult for the bone marrow to produce healthy blood cells and platelets, which puts patients at higher risk of infection and abnormal bleeding. One therapy for myeloma is bortezomib, a drug classified as a proteasome inhibitor for its activity blocking the proteasome (a cell structure that regulates the proteins involved in cell replication and survival), which prevents the function of proteins essential for myeloma cell survival. Another myeloma treatment strategy involves immunomodulatory agents, such as lenalidomide, which bolster the immune system's response to myeloma and alter the tumor microenvironment that sustains cancer cell growth. While each therapy is individually effective, when combined they offer improved response rates and lead to longer duration of response.

While immunomodulatory agents are produced in convenient oral pill form, bortezomib must be administered via injection and carries a risk of nerve damage, which can deter patient adherence to treatment regimens. MLN9708, the first oral proteasome inhibitor to enter clinical trials for the treatment of myeloma, may offer a more convenient and tolerable form of treatment that limits the risk of nerve damage.

In order to assess the efficacy, safety, and proper dose of MLN9708 in previously untreated myeloma patients, researchers enrolled 65 patients in a
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Researchers develop novel 3-D culture system for inflammatory breast cancer
2. ACNP: Novel NMDA receptor modulator significantly reduces depression scores within hours
3. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
4. Novel mechanism through which normal stromal cells become cancer-promoting cells identified
5. Novel breast screening technology increases diagnostic accuracy
6. UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
7. Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
8. Novel treatment strategies for epilepsy
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Researchers ID potential patient population who may benefit from novel anti-platelet treatment
11. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... 2014 Lifeinsurancenomedicalexam.info has released a ... for clients who have high cholesterol levels. , ... and qualify for no medical exam life insurance. These ... background medical check-ups. , Since there are no medical ... will qualify in just a few minutes. However, this ...
(Date:8/1/2014)... Cincinnati, Ohio (PRWEB) August 01, 2014 ... in-home care for seniors, is honored to be recognized as ... prestigious award is given to home care providers who rank ... satisfaction categories, based on monthly satisfaction interviews conducted by Home ... recognize the leading home care businesses, the best of the ...
(Date:8/1/2014)... In recent years, minimally invasive aesthetic injectable procedures have ... women are seeking age-defying treatments. As Botulinum toxin ... a growing number of nonaesthetic health professionals have emerged ... Small, MD and Henry M. Spinelli, MD from the ... and Kathleen M. Kelly, MD from Columbia University in ...
(Date:8/1/2014)... 2014 CapsCanada, a leading provider ... a new K-CAPS® (HPMC capsules) manufacturing facility in ... plans last year while experiencing growing global demand ... Manager, “KCAPS® are currently sold in more than ... “Compared to other HPMC capsules, K-CAPS® have exceptional ...
(Date:8/1/2014)... MA (PRWEB) August 01, 2014 For ... even when memory is still within the normal range, ... warning signs of future decline. This merits a closer ... in the August 2014 Harvard Men's Health Watch ... that if they forget where their keys are they ...
Breaking Medicine News(10 mins):Health News:No Exam Life Insurance - Coverage for Clients Who Have High Cholesterol 2Health News:Cincinnati Senior Care Company Receives 2014 Best of Home Care® Employer of Choice Award 2Health News:Plastic surgeons or nurses: Who are the better injectors? 2Health News:Worried About Changes in Your Memory? It's Worth A Closer Look, From the August 2014 Harvard Men's Health Watch 2
... Four-legged heroes -- cats, too -- are maintaining the veterinary ... most of America,s blood donors, JJ and Logan are unaware ... saved. , But over a three-year period, the two healthy ... numerous canine patients survive surgeries and illnesses to play "fetch" ...
... Colo., April 18 Mesa Laboratories,Inc., (Nasdaq: MLAB ... will participate in a Health-Care Trade Policy Mission led ... selected as one of 15 companies,to accompany Under Secretary ... purpose of the mission is to provide a forum ...
... ROSEVILLE, Calif., April 18 CoolTouch Inc., ... introduction,of their new CoolBlue Duet(TM) laser lipolysis suction ... CoolLipo(TM) 1320 laser system.,Using a standard liposuction cannula, ... in one action, which dramatically reduces,the time of ...
... Supermarket,Company is alerting customers to a voluntary recall by Chang ... a sell by date of April 19,2008 and a UPC ... recalled because of the possible presence of,Listeria bacteria. Contamination with ... public health., Upon being notified of the recall, Stop ...
... April 17 The state,s Life Sciences Discovery,fund ... phase 1 clinical-trials,program to test new therapies for ... this evening, the grant is among the first,funded ... novel therapies targeted to treat solid tumors, in,collaboration ...
... cancer may have an Achilles, heel, report suggests , , THURSDAY, ... forced metastatic melanoma into remission for the first time, report ... case involves a 79-year-old woman with melanoma tumors in several ... in a gene called KIT, so the patient was enrolled ...
Cached Medicine News:Health News:Donor Dogs Give the Gift of Life 2Health News:Donor Dogs Give the Gift of Life 3Health News:Donor Dogs Give the Gift of Life 4Health News:CoolTouch Introduces CoolBlue Duet(TM) Laser Lipolysis Suction Handpiece 2Health News:Life Sciences Discovery Fund Awards $2.2 Million to Support New Solid-Tumor Research Program 2Health News:Gleevec Pushes Advanced Melanoma Into Remission 2
(Date:7/31/2014)... , July 31, 2014  UBM Medica US announces ... online community for oncologists, presents exclusive slide shows dealing ... essential to quality cancer care. Cancer ... ONCOLOGY , offers news, blogs, and podcasts about the ... quality cancer care: , End-of-life care is ...
(Date:7/31/2014)...  A substantial share of pharmacy and therapeutics ... are included in formularies—say patient support resources from ... Manhattan Research study, Taking the Pulse® Formulary ... P&T committee members in hospitals, managed care organizations ... a high bar for these programs, requiring that ...
(Date:7/31/2014)... , July 31, 2014 For its ... California , Art,s-Way Scientific has earned a ... With competition in over 30 categories, MBI,s contest ... MBI members, which include building manufacturers, dealers, and product ... an excellent example the capability of our team," said ...
Breaking Medicine Technology:Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4
... The RetCam II is a mobile, self-contained system ... office. It provides state-of-the-art Wide-Field Pediatric Retinal Imaging. ... entire exam and document almost the entire retina with ... RetCam II is our 3 CCD medical grade digital ...
... The new Riata ... physicians even more versatility ... high defibrillation thresholds (DFTs)., ... lead family allows physicians ...
... of use with high software functionality ... guided system for neurosurgery that is ... With a 50% usage rate and ... 500 physicians, VectorVision Cranial is the ...
... system delivers on the promise of ... the latest advancement in fluidics control ... Lomb Surgical offers CONCENTRIX™ Fluidics Control ... provide both flow and vacuum response. ...
Medicine Products: